Literature DB >> 27330055

Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment.

Meric Erikci Ertunc1, Gökhan S Hotamisligil2.   

Abstract

Lipids encompass a wide variety of molecules such as fatty acids, sterols, phospholipids, and triglycerides. These molecules represent a highly efficient energy resource and can act as structural elements of membranes or as signaling molecules that regulate metabolic homeostasis through many mechanisms. Cells possess an integrated set of response systems to adapt to stresses such as those imposed by nutrient fluctuations during feeding-fasting cycles. While lipids are pivotal for these homeostatic processes, they can also contribute to detrimental metabolic outcomes. When metabolic stress becomes chronic and adaptive mechanisms are overwhelmed, as occurs during prolonged nutrient excess or obesity, lipid influx can exceed the adipose tissue storage capacity and result in accumulation of harmful lipid species at ectopic sites such as liver and muscle. As lipid metabolism and immune responses are highly integrated, accumulation of harmful lipids or generation of signaling intermediates can interfere with immune regulation in multiple tissues, causing a vicious cycle of immune-metabolic dysregulation. In this review, we summarize the role of lipotoxicity in metaflammation at the molecular and tissue level, describe the significance of anti-inflammatory lipids in metabolic homeostasis, and discuss the potential of therapeutic approaches targeting pathways at the intersection of lipid metabolism and immune function.
Copyright © 2016 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  diabetes; inflammation; insulin resistance; lipids; obesity; signaling lipids

Mesh:

Substances:

Year:  2016        PMID: 27330055      PMCID: PMC5321214          DOI: 10.1194/jlr.R066514

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  244 in total

Review 1.  Inflammation and metabolic disorders.

Authors:  Gökhan S Hotamisligil
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

2.  Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation.

Authors:  Peter Plomgaard; Karim Bouzakri; Rikke Krogh-Madsen; Bettina Mittendorfer; Juleen R Zierath; Bente K Pedersen
Journal:  Diabetes       Date:  2005-10       Impact factor: 9.461

3.  Circulating adipocyte fatty acid-binding protein levels are independently associated with heart failure.

Authors:  Mingya Liu; Mi Zhou; Yuqian Bao; Zhiyong Xu; Huating Li; Hao Zhang; Wei Zhu; Jialiang Zhang; Aimin Xu; Meng Wei; Weiping Jia
Journal:  Clin Sci (Lond)       Date:  2013-01       Impact factor: 6.124

4.  TLR4 antagonist attenuates atherogenesis in LDL receptor-deficient mice with diet-induced type 2 diabetes.

Authors:  Zhongyang Lu; Xiaoming Zhang; Yanchun Li; Maria F Lopes-Virella; Yan Huang
Journal:  Immunobiology       Date:  2015-06-30       Impact factor: 3.144

5.  Palmitoleate Reverses High Fat-induced Proinflammatory Macrophage Polarization via AMP-activated Protein Kinase (AMPK).

Authors:  Kenny L Chan; Nicolas J Pillon; Darshan M Sivaloganathan; Sheila R Costford; Zhi Liu; Marine Théret; Benedicte Chazaud; Amira Klip
Journal:  J Biol Chem       Date:  2015-05-18       Impact factor: 5.157

6.  Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes.

Authors:  Umut Ozcan; Qiong Cao; Erkan Yilmaz; Ann-Hwee Lee; Neal N Iwakoshi; Esra Ozdelen; Gürol Tuncman; Cem Görgün; Laurie H Glimcher; Gökhan S Hotamisligil
Journal:  Science       Date:  2004-10-15       Impact factor: 47.728

7.  Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia-reperfusion.

Authors:  I Ben Mosbah; I Alfany-Fernández; C Martel; M A Zaouali; M Bintanel-Morcillo; A Rimola; J Rodés; C Brenner; J Roselló-Catafau; C Peralta
Journal:  Cell Death Dis       Date:  2010-07-08       Impact factor: 8.469

8.  log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males.

Authors:  Michel P Hermans; Sylvie A Ahn; Michel F Rousseau
Journal:  Cardiovasc Diabetol       Date:  2010-12-14       Impact factor: 9.951

9.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

10.  JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation.

Authors:  Myoung Sook Han; Dae Young Jung; Caroline Morel; Saquib A Lakhani; Jason K Kim; Richard A Flavell; Roger J Davis
Journal:  Science       Date:  2012-12-06       Impact factor: 47.728

View more
  120 in total

1.  Targeting DGAT1 Ameliorates Glioblastoma by Increasing Fat Catabolism and Oxidative Stress.

Authors:  Xiang Cheng; Feng Geng; Meixia Pan; Xiaoning Wu; Yaogang Zhong; Chunyan Wang; Zhihua Tian; Chunming Cheng; Rui Zhang; Vinay Puduvalli; Craig Horbinski; Xiaokui Mo; Xianlin Han; Arnab Chakravarti; Deliang Guo
Journal:  Cell Metab       Date:  2020-06-18       Impact factor: 27.287

2.  Oral Azelaic Acid Ester Decreases Markers of Insulin Resistance in Overweight Human Male Subjects.

Authors:  Robert T Streeper; Elzbieta Izbicka; Christopher Louden
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

3.  Effects of high-fat diet and AMP-activated protein kinase modulation on the regulation of whole-body lipid metabolism.

Authors:  Milena Schönke; Julie Massart; Juleen R Zierath
Journal:  J Lipid Res       Date:  2018-05-08       Impact factor: 5.922

Review 4.  Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication.

Authors:  Jan-Bernd Funcke; Philipp E Scherer
Journal:  J Lipid Res       Date:  2019-06-17       Impact factor: 5.922

Review 5.  Manipulation of intestinal microbiome as potential treatment for insulin resistance and type 2 diabetes.

Authors:  Yasaman Ghorbani; Katherine J P Schwenger; Johane P Allard
Journal:  Eur J Nutr       Date:  2021-03-02       Impact factor: 5.614

6.  Hepatic PLIN5 signals via SIRT1 to promote autophagy and prevent inflammation during fasting.

Authors:  Enxiang Zhang; Wenqi Cui; Michael Lopresti; Mara T Mashek; Charles P Najt; Hongbo Hu; Douglas G Mashek
Journal:  J Lipid Res       Date:  2020-01-13       Impact factor: 5.922

Review 7.  Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASH.

Authors:  Y Ilan; K Shailubhai; A Sanyal
Journal:  Clin Exp Immunol       Date:  2018-09       Impact factor: 4.330

8.  Diet, Genetics, and the Gut Microbiome Drive Dynamic Changes in Plasma Metabolites.

Authors:  Shiho Fujisaka; Julian Avila-Pacheco; Marion Soto; Aleksandar Kostic; Jonathan M Dreyfuss; Hui Pan; Siegfried Ussar; Emrah Altindis; Ning Li; Lynn Bry; Clary B Clish; C Ronald Kahn
Journal:  Cell Rep       Date:  2018-03-13       Impact factor: 9.423

9.  Individual serum saturated fatty acids and markers of chronic subclinical inflammation: the Insulin Resistance Atherosclerosis Study.

Authors:  Ingrid D Santaren; Steven M Watkins; Angela D Liese; Lynne E Wagenknecht; Marian J Rewers; Steven M Haffner; Carlos Lorenzo; Andreas Festa; Richard P Bazinet; Anthony J Hanley
Journal:  J Lipid Res       Date:  2017-09-19       Impact factor: 5.922

10.  Renal complications of lipodystrophy: A closer look at the natural history of kidney disease.

Authors:  Baris Akinci; Sadiye Mehtat Unlu; Ali Celik; Ilgin Yildirim Simsir; Sait Sen; Banu Nur; Fatma Ela Keskin; Basak Ozgen Saydam; Nilufer Kutbay Ozdemir; Banu Sarer Yurekli; Bekir Ugur Ergur; Melda Sonmez; Tahir Atik; Atakan Arslan; Tevfik Demir; Canan Altay; Ulku Aybuke Tunc; Tugba Arkan; Ramazan Gen; Erdal Eren; Gulcin Akinci; Aslihan Arasli Yilmaz; Habib Bilen; Samim Ozen; Aygul Celtik; Senay Savas Erdeve; Semra Cetinkaya; Huseyin Onay; Sulen Sarioglu; Elif Arioglu Oral
Journal:  Clin Endocrinol (Oxf)       Date:  2018-05-17       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.